Thyroid Artery Embolization for the Treatment of Compressive Goiters.

Recruiting now · Not applicable

Conditions studied: Thyroid Nodules

In brief

Very few studies have investigated TAE as a treatment for goiter with compressive symptoms. What is the efficacy and safety of TAE for the treatment of compressive goiters in a population ineligible for or refusing standard therapy? This is a prospective interventional cohort study that will allow us to standardize imaging by improving quality data collection and fellow-up to assess the efficacy of TAE for compressive symptoms of nodular goiters. Not only to corroborate current emerging results but clearly define the expected results for this technique.

Key facts

Study ID

NCT07360587

Run by

Université de Sherbrooke

People needed

20

Starts

2026-01-31

Expected to finish

2029-12-31

Last updated by the study team

2026-01-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient with compressive symptoms or significant tracheal or oesophageal compression at risk of causing symptoms attributed to a goiter AND
• Ineligible for surgery/ablative treatments or preference for TAE over other treatments AND
• TiRADS category 1, 2, 3 or 4 AND
• Bethesda categories I or III on 2 different biopsies OR Bethesda II on one biopsy AND
• Patient at least 18 years old.

You may not qualify if…

• Comorbidities precluding endovascular procedure OR
• TiRADS category 5 OR
• Bethesda categories IV, V, VI on biopsy OR
• Refusal of the patient to participate OR
• Uncontrolled severe hyperthyroidism OR
• Minor patient.

Where it is running

• Centre Hospitalier Universitaire de Sherbrooke — Sherbrooke, Quebec, Canada (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.